{
    "nctId": "NCT04932460",
    "briefTitle": "Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy",
    "officialTitle": "A Prospective Multi-center Study: Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy After Neoadjuvant Therapy in Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 350,
    "primaryOutcomeMeasure": "False negative rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u226518 years old female\uff1b\n* ECOG\uff1a0 - 1\uff1b\n* Biopsy confirmed invasive breast cancer\uff1b\n* cT1-4N0-3\uff1b\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Inflammatory breast cancer\uff1b\n* Received ipsilateral axillary surgery previously\uff1b\n* During pregnancy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}